claim
Lipoprotein-associated phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) have an additive effect on coronary artery disease (CAD) risk prediction.
Authors
Sources
- EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org via serper
Referenced by nodes (2)
- C-reactive protein concept
- coronary artery disease concept